Sharpe ratio
0.73Return earned for the risk taken.
Moderate
Moderate risk-adjusted returns. The reward for risk has been average.
-0.58%1Y Absolute Return
-0.39%1D
Loading NAV history…
Past performance is not an indicator of future returns.
Returns calculator comparison
Compare an illustrative investment outcome across return assumptions.
| Asset | Projected corpus | Total invested | Gain | Annual return |
|---|---|---|---|---|
| Franklin India Mid Cap Fund - Direct - GrowthFund 5Y annualised return | ₹9,97,862 | ₹7,32,612 | ₹2,65,250 | +12.52% |
| EPFIllustrative annual assumption | ₹8,95,132 | ₹7,32,612 | ₹1,62,520 | +8.25% |
| Residential propertyIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| PPFIllustrative annual assumption | ₹8,69,819 | ₹7,32,612 | ₹1,37,207 | +7.10% |
| Bank fixed depositIllustrative annual assumption | ₹8,56,981 | ₹7,32,612 | ₹1,24,369 | +6.50% |
| GoldIllustrative annual assumption | ₹8,67,662 | ₹7,32,612 | ₹1,35,050 | +7.00% |
| Savings accountIllustrative annual assumption | ₹7,86,827 | ₹7,32,612 | ₹54,215 | +3.00% |
Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.
Wealth multiple
₹1 became₹1.18
₹1 Lakh since launch₹1.18 Lakh
Fund age13.9 yrs
Fund information
Scheme code118533
ISININF090I01FH9
BenchmarkNIFTY Midcap 150 TRI
CategoryEquity Scheme - Mid Cap Fund
Expense ratio1.08%
Exit loadExit load of 1% if redeemed within 1 year
Minimum SIP₹500 SIP
Return comparison
98th / 127 in category| Period | Fund | Benchmark | Category avg |
|---|---|---|---|
| 1M | +56.83% | — | — |
| 3M | -13.47% | — | — |
| 6M | +9.51% | — | — |
| 1Y | -0.58% | — | +3.02% |
| 3Y | +14.74% | — | +13.42% |
| 5Y | +12.52% | — | +11.30% |
| 10Y | +14.82% | — | — |
| Since Launch | +17.58% | — | — |
Risk-adjusted performance
Every measure is expanded with a plain-language reading of the latest calculated value.
Sortino ratio
1.00Return earned while limiting downside risk.
Good
Good downside protection with strong returns.
Standard deviation
15.95%How much the fund’s returns fluctuate over time.
High volatility
Returns can swing significantly.
Beta
—How closely the fund moves with the market.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Alpha
—Extra return generated above the benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Treynor ratio
—Return earned for each unit of market risk taken.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Calmar ratio
0.48How well the fund rewarded investors relative to its biggest decline.
Low
Returns have been modest compared to the drawdowns experienced.
Information ratio
—How consistently the fund outperformed its benchmark.
Unavailable
This measure needs sufficient fund and benchmark history to calculate.
Portfolio allocation
Latest disclosed portfolio mix
Asset allocation
Portfolio100%
Equity96.27%
Cash3.53%
Debt0.20%
Market cap allocation
Sector allocation
Equity exposure by sector
Top holdings
10 of 76 disclosed positions
| Holding | Sector | Instrument type | Weight |
|---|---|---|---|
| Cash/Net Current Assets | Unspecified | Cash/Net Current Assets | 3.5273% |
| The Federal Bank Ltd | Financial | Equity | 2.7284% |
| IDFC First Bank Ltd | Financial | Equity | 2.348% |
| Mahindra & Mahindra Financial Services Ltd | Financial | Equity | 2.1273% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.0975% |
| Biocon Ltd | Healthcare | Equity | 2.0831% |
| Balkrishna Industries Ltd | Consumer Discretionary | Equity | 2.0513% |
| Prestige Estates Projects Ltd | Real Estate | Equity | 2.0443% |
| Tube Investments Of India Ltd | Consumer Discretionary | Equity | 2.0281% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.007% |
Fund management
SA
Sandeep Manam
Since 2021 · Prior to joining Franklin Templeton Asset Management (India) Pvt. Ltd., he has worked with Cognizant Technology Solutions, Shapoorji Pallonji & Company Private Limited.
Mr. Manam is a PGDM (IIM-Ahmedabad), B.Tech (Electronics & Communication Engg.)- National Institute of Technology Calicut
R
R Janakiraman
Since 2012 · Prior to joining Franklin Templeton Investments, he has worked with Indian Syntans Inv. Pvt. Ltd., Citicorp Information Tech Ltd. and UTI Securities Exchange Ltd.
Mr. Janakiraman is a B.E and PGDM (Business Management).
AK
Akhil Kalluri
Since 2022 · Prior to joining Franklin Templeton Mutual Fund, he has worked with Credit Suisse, ICICI Securities.
Mr. Kalluri is a MBA, IIM Lucknow. B.Tech. (Electronics and Communications Engineering), Andhra University
Compare similar funds
No comparable category funds are available yet.
Summary
A very high-risk equity scheme - mid cap fund. Ahead of its category average over 3Y by 1.3 points. Has fallen sharply before — down -36.6% at its worst.
Strengths
- Ahead of its category average over 3Y by 1.3 points.
- Well spread out — top 10 holdings are only 22% of the portfolio.
- Same fund manager for 14+ years — the strategy has not chopped and changed.
Weaknesses
- Has fallen sharply before — down -36.6% at its worst.
- Ranks 98 of 127 in its category over 1 year.
Ideal investor
- Needs a 5–7+ years horizon to ride out its very high risk level.
- Good fit for SIPs — spreading purchases smooths out 15.9% volatility.
Risk drivers
- Corrections have been sharp — worst fall -36.6% with 15.9% volatility. Took 8 months to recover last time.